Thursday, May 16, 2019 3:15:51 PM
Dr. Walt will lead the global medical function dedicated to strengthening CannTrust's clinical research strategy, medical education programs, product innovation and support the expansion of CannTrust's global medical businesses and partnerships.
"Adding Dr. Walt to our senior leadership team supports our commitment to developing a world-class global medical function that will drive our international growth and partnership strategy," said Peter Aceto, Chief Executive Officer, CannTrust. "As we continue to grow, Dr. Walt's leadership and experience will be pivotal to ensure we continue our commitment to industry-leading research and product development."
Dr. Walt comes to CannTrust with extensive senior leadership experience in the pharmaceutical and biotechnology industries in Canada, USA and abroad. Most recently Dr. Walt held the position of Vice President and Head of Medical Affairs at Sobi Inc., where he led their North American medical and scientific operations. Previously, Dr. Walt held the position of Medical Director at Biogen Canada where he built best-in-class medical teams and developed strong relationships with key clinical investigators in Canada.
"What inspired me to take on this role is a strong belief in the significant clinical benefits cannabis can offer patients suffering from serious conditions," said Dr. Len Walt, Chief Medical Officer, CannTrust. "My goal is to develop a world-class team that will conduct industry leading scientific research to further our understanding of cannabis and its therapeutic potential."
Recent TRST News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:19:59 PM
- Apple Loses Market Share in China, GM Surges in Pre-Market Following Upward Revisions for 2024 Projections, and More News • IH Market News • 04/23/2024 11:25:34 AM
- Loans Reach Another All-Time High, Credit Quality Remains Solid; TrustCo Reports Net Income of $12.1 Million and Capital Up 3% • GlobeNewswire Inc. • 04/22/2024 08:00:00 PM
- TrustCo to Release First Quarter 2024 Results on April 22, 2024; Conference Call on April 23, 2024 • GlobeNewswire Inc. • 04/10/2024 08:00:00 PM
- TrustCo Bank Corp NY Announces Stock Repurchase Plan • GlobeNewswire Inc. • 03/29/2024 08:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 08:51:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 07:21:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:01:31 PM
- Strong Capital Supports TrustCo’s Consistent Dividend; Annualized Payout of $1.44 per share • GlobeNewswire Inc. • 02/21/2024 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:37:49 PM
- Form 13F-HR - Quarterly report filed by institutional managers, Holdings • Edgar (US Regulatory) • 02/14/2024 06:11:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 09:02:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 10:10:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:01:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:00:26 PM
- TrustCo to Release Fourth Quarter 2023 Results on January 22, 2024; Conference Call on January 23, 2024 • GlobeNewswire Inc. • 01/10/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 03:49:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:11:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:10:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:08:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:07:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:05:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:03:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:01:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 08:58:58 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM